Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Tumor-infiltrating lymphocytes for the treatment of metastatic cancerGeukes Foppen, M.H. ; Donia, M. ; Svane, I.M. ; Haanen, J.B.A.G.Molecular oncology, 2015-12, Vol.9 (10), p.1918-1935 [Periódico revisado por pares]United States: Elsevier B.VTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Clinical Pharmacokinetics of Vemurafenib in BRAF‐Mutated Melanoma PatientsNijenhuis, C. M. ; Huitema, A. D. R. ; Blank, C. ; Haanen, J. B. A. G. ; Thienen, J. V. ; Rosing, H. ; Schellens, J. H. M. ; Beijnen, J. H.Journal of clinical pharmacology, 2017-01, Vol.57 (1), p.125-128 [Periódico revisado por pares]England: American College of Clinical PharmacologyTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Survival of stage IV melanoma in Belgium and the NetherlandsSuijkerbuijk, K.P.M. ; Haanen, J.B.A.G. ; Boers‐Sonderen, M.J. ; Hospers, G.A.P. ; Blank, C.U. ; den Berkmortel, F.W.P.J. ; Groot, J.W.B. ; Piersma, D. ; Aarts, M.J.B. ; Rijn, R.S. ; Vreugdenhil, G. ; Westgeest, H.M. ; Kapiteijn, E. ; Veldt, A.A.M. ; den Eertwegh, A.J.M.Journal of the European Academy of Dermatology and Venereology, 2022-02, Vol.36 (2), p.e118-e119 [Periódico revisado por pares]EnglandTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib-Induced HypertensionEechoute, K ; van der Veldt, A A M ; Oosting, S ; Kappers, M H W ; Wessels, J A M ; Gelderblom, H ; Guchelaar, H-J ; Reyners, A K L ; van Herpen, C M L ; Haanen, J B ; Mathijssen, R H J ; Boven, EClinical pharmacology and therapeutics, 2012-10, Vol.92 (4), p.503-510 [Periódico revisado por pares]United States: Blackwell Publishing LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Lack of anti‐tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinomaVyth‐Dreese, F.A ; Sein, J ; Van De Kasteele, W ; Dellemijn, T.A.M ; Van Den Bogaard, C ; Nooijen, W.J ; De Gast, G.C ; Haanen, J.B.A.G ; Bex, AClinical and experimental immunology, 2010-12, Vol.162 (3), p.447-459 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Improved Survival In Patients With Advanced Melanoma In Real-World Clinical Practice: First Results Of The Dutch Melanoma Treatment RegistryLeeneman, B ; Franken, MG ; Jochems, A ; Schouwenburg, MG ; Wouters, MW ; Van den Eertwegh, AJ ; Haanen, JB ; Van der Hoeven, KJ ; Uyl - de Groot, CAValue in health, 2015-11, Vol.18 (7), p.A440-A441 [Periódico revisado por pares]United StatesTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Improved Survival With Ipilimumab In Patients With Advanced Melanoma In Real-World Clinical Practice: First Results Of The Dutch Melanoma Treatment RegistryLeeneman, B ; Franken, MG ; Jochems, A ; Schouwenburg, MG ; Wouters, MW ; Van den Eertwegh, AJ ; Haanen, JB ; Van der Hoeven, KJ ; Uyl - de Groot, CAValue in health, 2015-11, Vol.18 (7), p.A440-A440 [Periódico revisado por pares]United StatesTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Seasonal variation of anti‐PD‐1 outcome in melanoma—Results from a Dutch patient cohortBorgers, J. S. W. ; Burgers, F. H. ; Schina, A. ; Van Not, O. J. ; Eertwegh, A. J. M. ; Blank, C. U. ; Aarts, M. J. B. ; Berkmortel, F. W. P. J. ; Groot, J. W. B. ; Hospers, G. A. P. ; Kapiteijn, E. ; Piersma, D. ; Rijn, R. S. ; Boer, A. M. Stevense‐den ; Veldt, A. A. M. ; Vreugdenhil, G. ; Boers‐Sonderen, M. J. ; Wouters, M. W. J. M. ; Suijkerbuijk, K. P. M. ; Thienen, J. V. ; Haanen, J. B. A. G.Pigment cell and melanoma research, 2024-01, Vol.37 (1), p.15-20 [Periódico revisado por pares]England: Wiley Subscription Services, IncTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Real-world outcomes of advanced melanoma patients not represented in phase III trialsvan Zeijl, M C T ; Ismail, R K ; de Wreede, L C ; van den Eertwegh, A J M ; de Boer, A ; van Dartel, M ; Hilarius, D L ; Aarts, M J B ; van den Berkmortel, F W P J ; Boers-Sonderen, M J ; de Groot, J W B ; Hospers, G A P ; Kapiteijn, E ; Piersma, D ; van Rijn, R S ; Suijkerbuijk, K P M ; Ten Tije, A J ; van der Veldt, A A M ; Vreugdenhil, G ; Haanen, J B A G ; Wouters, M W J M2020-12Texto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Real-world outcomes of advanced melanoma patients not represented in phase III trialsvan Zeijl, M C T ; Ismail, R K ; de Wreede, L C ; van den Eertwegh, A J M ; de Boer, A ; van Dartel, M ; Hilarius, D L ; Aarts, M J B ; van den Berkmortel, F W P J ; Boers-Sonderen, M J ; de Groot, J W B ; Hospers, G A P ; Kapiteijn, E ; Piersma, D ; van Rijn, R S ; Suijkerbuijk, K P M ; Ten Tije, A J ; van der Veldt, A A M ; Vreugdenhil, G ; Haanen, J B A G ; Wouters, M W J M2020-12Texto completo disponível |